Market Overview
Fluoroscopy
can be defined as an imaging technique, which uses X-Ray technology for taking
real-time images of the body. It allows the physicians to visualize muscles,
organs, and bones, which further helps them to make crucial decisions during
surgery. Fluoroscopy and Mobile C-Arms Market
ShareSize is
anticipated to reach USD 4.32 Billion by 2032 at 4.7% CAGR during the forecast period
2023-2032.
Factors
like the rising incidence of chronic diseases, ever-increasing geriatric
population, and high adoption of fluoroscopy in neurological and orthopedic
procedures will supplement the market growth in the segment. Improving
healthcare infrastructure, advancing technology in fluoroscopy and C-arms
equipment, and increasing number of interventional radiology surgeries are
likely to elevate the scope for the market across the globe. Moreover, rapid
product launches and rising number of mergers and acquisitions will further
contribute to the market growth in the long run. The shift towards a
value-based healthcare model, surging adoption of minimally invasive surgeries,
and soaring demand for improved imaging technology are likely to promote the
market growth in the coming years.
On the
contrary, the high cost of fluoroscopic and mobile c-arm systems,
coupled with the risk of radiation exposure are some of the key concerns likely
to restrict the market growth across the globe.
Fluoroscopy
and Mobile C-Arms Market Outlook and Report
Analysis By Device Type (Fluoroscopy Systems
& Mobile C-Arms), Application (Gastrointestinal, Orthopedics, Neurology,
& Others), End User (Hospital & Clinics & Others), Region -
Forecast till 2030
Competitive
Dashboard
The top
operating in the Fluoroscopy and Mobile C-Arms Market Players scope include
Canon Medical Systems Corporation (Japan), Allengers Medical Systems (India),
GE Healthcare (US), DMS Group (France), Hologic Inc. (US), Hitachi Ltd (Tokyo),
OrthoScan, Inc. (the US), Omega Medical Imaging, LLC (US), Shimadzu Corporation
(Japan), Koninklijke Philips N.V. (The Netherlands), Varian Medical Systems,
Inc. (US), Siemens (Germany), Ziehm Imaging GmbH (US), and Villa Sistemi
Medicali Spa (Italy).
Global
Fluoroscopy and Mobile C-Arms Market: Segmental Analysis
The Fluoroscopy
and Mobile C-Arms Market analysis has been segmented on the basis of
application, device type, and end user.
·
By device type,
the market is segmented into fluoroscopy systems and mobile c-arms. Of these,
the mobile C-arms segment will gain significant prominence, mainly due to the
soaring incidence of cardiovascular disease and the rising number of orthopedic
surgeries. C-arms are extensively used for surgeries of cardiovascular
diseases, gastroenterology, neurosurgeries, traumatology, orthopedics, and
urology disorders.
·
The market finds application in orthopedics, gastrointestinal, cardiovascular, pain management and trauma, urology, neurology, and
others. Of these, the cardiovascular application will gain prominence due to
the increased burden of cardiovascular diseases and better results offered by
fluoroscopy systems during treatment and diagnosis.
·
Based on the end users, the market constitutes diagnostic centers, hospital and clinics,
research and academic institutes, and others. Of these, the hospital and
clinics segment accounted for USD 895.96 million in 2017. The high adoption of
advanced and sophisticated imaging systems will drive the market growth in the
segment.
Regional
Frontiers
Geographically,
the Fluoroscopy and Mobile C-Arms Market Outlook have been studied under
regions namely, Europe, the Americas, Asia Pacific, and the Middle East &
Africa.
Considering
the global scenario, the Americas is predicted to acquire the lion’s share and
dominate the market globally. In this region, North America is predicted to
command the largest share, mainly due to the acceptance of innovative and
latest products. Also, the surging awareness regarding medical imaging devices and rising financial capability to
purchase expensive machines are driving the market growth in the region.
Europe is
likely to register moderate growth in the foreseeable future. The regional
growth can be credited to the surging prevalence of road accidents, which leads
to orthopedic surgeries. The rising expenditure in the healthcare sector and
increasing R&D activities will further contribute to the market growth in
the long run.
Meanwhile,
the Asia Pacific will register the fastest growth across the globe. Developing
countries like India, China, and South Korea are gradually becoming major
destinations for pathology testing and outsourcing clinical trials. This is
likely to elevate the scope of the market in the region. The presence of
untapped opportunities, surging awareness about medical imaging techniques and
applications, and improving healthcare infrastructure are encouraging the
regional market’s growth.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
